Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. (Q45908097)

17 December 2017

title

Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. (English)

1 reference

17 December 2017

main subject

Streptococcus pneumoniae

1 reference

inferred from title

antibiotic resistance

1 reference

M Hackel

1

1 reference

17 December 2017

C Lascols

2

1 reference

17 December 2017

S Bouchillon

3

1 reference

17 December 2017

B Hilton

4

1 reference

17 December 2017

D Morgenstern

5

1 reference

17 December 2017

J Purdy

6

1 reference

17 December 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

17 December 2017

published in

Vaccine

1 reference

17 December 2017

volume

31

1 reference

17 December 2017

issue

42

1 reference

17 December 2017

page(s)

4881-4887

1 reference

17 December 2017

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Burden of community-acquired pneumonia in North American adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Severe community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Epidemiology of community-acquired pneumonia in older adults: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Occurrence, distribution, and origins of Streptococcus pneumoniae Serotype 6C, a recently recognized serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Antibiotic resistance in invasive Streptococcus pneumoniae isolates identified in Scotland between 1999 and 2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

The pneumococcus: carriage, disease and conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

7 January 2021

inferred from DOI database lookup

Six newly recognized types of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.054

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2013.07.054

1 reference

17 December 2017

release_rhtf7klqjjgzjavpe2xolurh64

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rhtf7klqjjgzjavpe2xolurh64

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017